[Clinical studies of beta-methyl-digoxin in patients with cardiac decompensation].
The results are reported from the observations on the activity of the semi-synthetic preparation beta-Methyl-Digoxin in 60 patients with chronic cardiac insufficiency. The conclusions are based on the data, obtained by a series of clinical and instrumental examinations, electro- and balistocardiography included, measurements of venous pressure, etc. The high efficiency and good tolerance of the preparation is stressed upon. It is stressed to be especially suitable for the treatment of patients with bradycardic form of chronic heart decompensation as well as in the treatment of cardiac cirrhosis.
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001450:Ballistocardiography; D002031:Bulgaria; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D004077:Digoxin
Klinichni prouchvaniia vurkhu beta-methy-digoxin pri bolni sus surdechna dekompensatsiia